ストックスクリーナーアプリを入手
178.43
0.50%
-0.90
前日終値:
$179.33
開ける：
$178
24時間の取引高:
832.99K
Relative Volume:
0.88
時価総額：
$19.95B
収益：
$9.54B
当期純損益:
$841.00M
株価収益率:
23.98
EPS:
7.44
ネットキャッシュフロー:
$1.02B
1週間 パフォーマンス:
-5.51%
1か月 パフォーマンス:
-2.76%
6か月 パフォーマンス:
+8.68%
1年 パフォーマンス:
+18.33%
1日の値動き範囲:
$177.39
$179.62
1週間の範囲:
$177.39
$191.49
52週間の値動き範囲:
$146.17
$191.49
Quest Diagnostics Inc Stock (DGX) Company Profile
DGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
178.43 | 20.05B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
543.95 | 205.16B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
211.71 | 153.94B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
627.78 | 50.50B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.61 | 40.16B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.02 | 35.13B | 15.70B | 1.24B | 2.01B | 6.9036 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 開始されました | Redburn Atlantic | Buy |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-01-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | Jefferies | Buy |
| 2024-10-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 再開されました | Evercore ISI | In-line |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-12-12 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-06-29 | 開始されました | Piper Sandler | Neutral |
| 2023-05-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-01-23 | 開始されました | Evercore ISI | In-line |
| 2022-11-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-04-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-23 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-02 | ダウングレード | Jefferies | Buy → Hold |
| 2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-04 | アップグレード | UBS | Neutral → Buy |
| 2021-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | アップグレード | Argus | Hold → Buy |
| 2020-07-29 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-09 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-04-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
| 2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-12-19 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | ダウングレード | Goldman | Neutral → Sell |
| 2019-04-02 | アップグレード | Jefferies | Hold → Buy |
| 2019-03-18 | 再開されました | Credit Suisse | Neutral |
| 2019-01-31 | ダウングレード | Argus | Buy → Hold |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Quest Diagnostics Inc (DGX) 最新ニュース
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollarMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Will Quest Diagnostics Incorporated stock hit analyst forecastsInsider Buying & Real-Time Market Trend Scan - newser.com
Is Quest Diagnostics Incorporated (QDI) stock a top pick for value investorsJuly 2025 Movers & Low Drawdown Momentum Ideas - newser.com
Why Quest Diagnostics Incorporated stock could rally stronglyJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Will Quest Diagnostics Incorporated continue its uptrend2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
How Quest Diagnostics Incorporated (QDI) stock responds to job market shiftsWeekly Risk Report & Stepwise Entry/Exit Trade Alerts - newser.com
Quest Diagnostics Incorporated stock daily chart insightsJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Quest Diagnostics: Investing In Healthcare's Future Today (NYSE:DGX) - Seeking Alpha
How Quest Diagnostics Incorporated (QDI) stock behaves in tightening cycles2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Evaluating Quest Diagnostics Incorporated with trendline analysis2025 Price Momentum & Smart Money Movement Tracker - newser.com
Technical analysis overview for Quest Diagnostics Incorporated stockTrade Risk Report & Community Consensus Stock Picks - newser.com
What to expect from Quest Diagnostics Incorporated in the next 30 daysWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Can Quest Diagnostics Incorporated stock sustain breakout momentumEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
How Quest Diagnostics Incorporated (QDI) stock moves in volatile trading sessionsJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Analyzing Quest Diagnostics Incorporated with multi timeframe chartsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
State of Alaska Department of Revenue Has $2.25 Million Stock Position in Quest Diagnostics Incorporated $DGX - Defense World
Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq
Quest Diagnostics Hits New 52-Week High of $189.23, Reflecting Strong Performance - Markets Mojo
Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News - GuruFocus
Barclays Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains Equalweight Rating - MarketScreener
Quest Diagnostics Hits New 52-Week High at $191.45, Surges 34.71% - Markets Mojo
Pack Health closing in Birmingham, nearly 100 people to be laid off - CBS 42
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing - Yahoo Finance
Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life - Nasdaq
350,000 Members Waitlisted: WHOOP's New Blood Testing Platform Combines Lab Work with 24/7 Wearable Data - Stock Titan
G&S Capital LLC Invests $1.26 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Quest Diagnostics (NYSE:DGX) Hits New 1-Year HighWhat's Next? - MarketBeat
Washington Capital Management Inc. Sells 2,550 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc (DGX) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
1.81%
大文字化:
|
ボリューム (24 時間):